Strides Pharma announces strong Q2FY20 performance
MUMBAI, 27 OCTOBER, 2019 (GPN): Key highlights Q2FY20 Financial Results: Strides’ Q2FY20 consolidated revenues stood at ₹7,180m demonstrating 37% YoY and 4% QoQ growth Consolidated EBITDA at ₹1,506m, up 210% YoY and 22% QoQ US…